Real Money on TheStreet - Free Previews
Independent market insight and actionable trade ideas from trusted Wall Street pros who aren't afraid to tell it like it is. Thousands of investors use Real Money
to hone their trading strategies and stay on top of the economic events, breaking news, and fast-moving trends influencing the market. Each day, our team of over 20 professional money managers, market technicians, and respected financial commentators -- including Jim Cramer, Jim "Rev Shark" Deporre, and Helene Meisler -- delivers intelligent analysis, timely trade ideas, and colorful commentary. You won't find a more honest or thoughtful approach to covering the markets.
With Real Money
you have all the information you need to make sound trading decisions in one dynamic platform. Try it Now! Free for 14 days
Real Money includes:
Reports on everything affecting the market
: Multiple perspectives on the latest trends, focused coverage of key financial developments, and in-depth features filled with straightforward candor.
Timely coverage and market insight
: No stone is left unturned. Our team of pros challenge each other's strategies and market predictions giving you the unique opportunity to see all sides of the story.
Action-specific trade ideas
: All of our professionals' latest trade ideas,frequently including price targets, are in one place so you can seize new opportunities -- fast.
Fast, efficient navigation
: Jump to specific sectors and asset classes and quickly view the articles and videos about the markets and issues you care about most.
Real Money Previews
Catch up on Jim Cramer's thinking over the last week about two leadership groups that have been hammered and the spike in oil.
Value simply means getting more for something than you pay for it.
Oil's sure not like it used to be.
Lam Research concerns me more than others in the semiconductor sector, and its failure to get green while many other big names are back at breakeven confirms it.
Good stocks come at a high price on Wall Street. Great ones carry a ridiculous price tag.
Warren Buffett's teaming up with 3G Capital on the Kraft-Heinz deal should send two of the biggest food companies into action.
Federal Reserve policy may inadvertently be a boon to the energy industry.
Playing the momentum game has its perils. Jim Cramer says beware the strong dollar and the loss of business to Europe.
If we just focus on price, Kimberly-Clark is at risk of losing this recent bullish trend line. Simply keep this one on the bullish watch list for now.
3M, Honeywell and Boeing should be missing numbers horribly as they contend with a strong dollar, weak emerging markets and subsidized competition. But they're not.
Starbucks trying to force its views on race on customers is too much, too soon and bad for business.
Major banks are suffering huge losses from backing some struggling oil companies as well as buying high-yield debt that is now going sour.
That isn't the time you want to be buying or hedging out against a long dollar position.
Better start paying attention to Simon Property Group's hot pursuit of Macerich because this combination would have several major ramifications.
The semiconductor group is as strong as I have ever seen it, dominating all tech when software, hardware, the Internet and the cloud are all in variation degrees of pausing.
A look at where are Celgene, Isis and CVS are heading.
Amgen last generated a long-term overbought condition on the Dec. 9 close of $169.39, and the shares then fell 13% to a Feb. 4 low of $147.42.
Lilly is moving to new highs while Amgen's momentum is declining.
Investors can handily beat the average by developing a portfolio of health care companies that try to service the colossus that is the American medical system.
The good news is that the 10-day moving average ETF put-call ratio is heading down and, typically, a downward-pointing moving average is supportive and bullish for the market.
In highlights from his trading diary of the past week, Kass discusses what a noted March Madness coach taught him about investing, and which sectors win on continued Fed dovishness.
Catch up on Jim Cramer's thinking over the last week about why you shouldn't dump biotech and the people with the best handle on the price of oil.
Here is what you should be continuing to search for ahead of the start of earnings season.
We don't seem to understand good when it bites us on the nose.
Wording from the Fed's policy statement is a wild card.
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a
comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and
strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV